Audiologists in Mason, OH Accepting Medicare

4 Audiologists found. Showing 1 - 4

Lisa R Rademacher Audiologist Medicare: Accepting Medicare Assignments Practice Location: 8197 Corporate Way, Mason, OH 45040 Phone: 513-628-0177    Fax: 513-548-0199

Kimberly Ann Combs, AUD DOCTOR OF AUDIOL Audiologist Medicare: Medicare Enrolled Practice Location: 6900 Tylersville Rd Ste B, Mason, OH 45040 Phone: 513-701-9322    Fax: 513-701-9324

Natalie Renay Klingenbeck Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6900 Tylersville Rd Ste B, Mason, OH 45040 Phone: 513-701-9322

Jeannie Marchionda, CCC Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6010 S Mason Montgomery Rd, Mason, OH 45040 Phone: 513-246-7000    Fax: 513-204-6355

News Archive

Research findings call for a rethinking of cancer genetics

Johns Hopkins researchers report that the deletion of any single gene in yeast cells puts pressure on the organism's genome to compensate, leading to a mutation in another gene. Their discovery, which is likely applicable to human genetics because of the way DNA is conserved across species, could have significant consequences for the way genetic analysis is done in cancer and other areas of research, they say.

NIH awards grants to treat HIV/AIDS in criminal justice system

Twelve scientific teams in more than a dozen states will receive National Institutes of Health (NIH) grants to study effective ways to prevent and treat HIV/AIDS among people in the criminal justice system.

Elderly cancer patients need custom-made treatment to combat the disease

Elderly cancer patients need a combination of treatments tailor-made to their specific needs to successfully combat the disease. The challenge is to boost their immune response to cancer vaccines, because like the rest of our organs, our immune system ages and gradually becomes less efficient as we get older.

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.

Read more Medical News

› Verified 6 days ago